XML 101 R87.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information (Schedule of Business Segments) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Segment Reporting Information [Line Items]          
Net sales $ 1,193 $ 1,592 $ 2,653 $ 3,279  
Other (charges) gains, net (Note 14) (21) (98) (27) (94)  
Operating profit (loss) 83 186 277 506  
Equity in net earnings (loss) of affiliates 31 39 88 89  
Depreciation and amortization 87 84 172 167  
Capital expenditures 80 [1] 74 [1] 166 [2] 128 [2]  
Goodwill and intangible assets, net 1,415   1,415   $ 1,386
Total assets 9,506   9,506   9,476
Increase (decrease) in accrued capital expenditures (8) 9 (41) (16)  
Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 127 164 256 330  
Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales [3] 646 835 1,414 1,693  
Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 420 593 983 1,256  
Operating Segments [Member] | Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 127 164 256 330  
Other (charges) gains, net (Note 14) 0 (84) (1) (84)  
Operating profit (loss) 31 (44) 58 (4)  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 9 11 17 21  
Capital expenditures 6 11 16 19  
Goodwill and intangible assets, net 152   152   153
Total assets 939   939   977
Operating Segments [Member] | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales 662 865 1,461 1,754  
Other (charges) gains, net (Note 14) 5 (1) 5 (1)  
Operating profit (loss) 121 188 256 390  
Equity in net earnings (loss) of affiliates 0 1 1 2  
Depreciation and amortization 42 38 81 76  
Capital expenditures 38 35 81 61  
Goodwill and intangible assets, net 278   278   234
Total assets 3,549   3,549   3,489
Operating Segments [Member] | Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 420 593 983 1,256  
Other (charges) gains, net (Note 14) (25) (8) (25) 7  
Operating profit (loss) (13) 103 89 247  
Equity in net earnings (loss) of affiliates 26 36 79 82  
Depreciation and amortization 32 31 66 63  
Capital expenditures 28 21 52 37  
Goodwill and intangible assets, net 985   985   999
Total assets 4,009   4,009   4,125
Corporate, Non-Segment [Member] | Other          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 0  
Other (charges) gains, net (Note 14) (1) (5) (6) (16)  
Operating profit (loss) (56) (61) (126) (127)  
Equity in net earnings (loss) of affiliates 5 2 8 5  
Depreciation and amortization 4 4 8 7  
Capital expenditures 8 7 17 11  
Goodwill and intangible assets, net 0   0   0
Total assets 1,009   1,009   885
Eliminations [Member]          
Segment Reporting Information [Line Items]          
Net sales (16) [4] (30) [4] (47) [5] (61) [5]  
Other (charges) gains, net (Note 14) 0 0 0 0  
Operating profit (loss) 0 0 0 0  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Capital expenditures 0 0 0 0  
Goodwill and intangible assets, net 0   0   0
Total assets 0   0   $ 0
Eliminations [Member] | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales $ 16 $ 30 $ 47 $ 61  
[1]
Includes a decrease in accrued capital expenditures of $8 million and an increase of $9 million for the three months ended June 30, 2020 and 2019, respectively.
[2]
Includes a decrease in accrued capital expenditures of $41 million and $16 million for the six months ended June 30, 2020 and 2019, respectively.
[3]
Excludes intersegment sales of $16 million and $30 million for the three months ended June 30, 2020 and 2019, respectively. Excludes intersegment sales of $47 million and $61 million for the six months ended June 30, 2020 and 2019, respectively.
[4]
Includes intersegment sales primarily related to the Acetyl Chain.
[5]
Includes intersegment sales primarily related to the Acetyl Chain.